Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 15/20 | 0.79 |
| ▸ | THRB | P10828 | 1/20 | 0.79 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | FYN | P06241 | 2/20 | 0.57 |
| ▸ | CYP51A1 | Q16850 | 2/20 | 0.57 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.57 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.57 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.57 |
| ▸ | PGR | P06401 | 1/20 | 0.57 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.57 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.57 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.57 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.57 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.57 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.57 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.57 |
| ▸ | DRD1 | P21728 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30582199 | 0.93 | CYP3A4 (0.68) | CYP3A4THRBCYP2C9LMNAFYN | |
| SCHEMBL30582188 | 0.93 | CYP3A4 (0.68) | CYP3A4THRBCYP2C9LMNAFYN | |
| Nitric Acid SCHEMBL11543901 | 0.92 | CYP3A4 (0.68) | CYP3A4THRBCYP2C9LMNAFYN | |
| SCHEMBL14019372 | 0.91 | CYP3A4 (0.66) | CYP3A4THRBCYP2C9LMNAFYN | |
| Difenoconazole SCHEMBL22126 | 0.90 | CYP3A4 (0.68) | CYP3A4THRBCYP2C9LMNAFYN | |
| Difenoconazole SCHEMBL3015472 | 0.90 | CYP3A4 (0.68) | CYP3A4THRBCYP2C9LMNAFYN | |
| Difenoconazole SCHEMBL15932941 | 0.90 | CYP3A4 (0.68) | CYP3A4THRBCYP2C9LMNAFYN | |
| Difenoconazole SCHEMBL20654517 | 0.90 | CYP3A4 (0.68) | CYP3A4THRBCYP2C9LMNAFYN | |
| Difenoconazole SCHEMBL22125 | 0.90 | CYP3A4 (0.68) | CYP3A4THRBCYP2C9LMNAFYN | |
| Difenoconazole SCHEMBL15932554 | 0.90 | CYP3A4 (0.68) | CYP3A4THRBCYP2C9LMNAFYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010047015-A1 | Pharmaceutical composition for inhibiting the growth of cancers | CAMDEN JAMES BERGER (US) | 2001-11-29 | — | — | US | claimed |
| US-20010039291-A1 | Compositions and methods of treatment for cancer or viral infections | THE PROCTER & GAMBLE COMPANY | 2001-11-08 | — | — | US | claimed |
| US-6228876-B1 | ADMINISTERING 1-(1,3-DIOXOLAN-2-YLMETHY)L- OR 1-(1,3-DIOXAN-2-YLMETHYL)-1H-1,2,4-TRIAZOLE DERIVATIVE | THE PROCTER & GAMBLE COMPANY | 2001-05-08 | — | — | US | claimed |
| US-6200992-B1 | ADMINISTERING 1H-1,2,4-TRIAZOLE DERIVATIVE, CHEMOTHERAPEUTIC AGENT, AND POTENTIATOR; ANTICARCINOGENIC, ANTITUMOR AGENTS | THE PROCTER & GAMBLE COMPANY | 2001-03-13 | — | — | US | claimed |
| US-6110953-A | Pharmaceutical composition for inhibiting the growth of cancers | THE PROCTER & GAMBLE COMPANY (US) | 2000-08-29 | — | — | US | claimed |
| US-6025377-A | 1H-1,2,4-TRIAZOLE DERIVATIVE. THESE COMPOUNDS CAN ALSO BE USED TO TREAT VIRAL INFECTIONS. | THE PROCTER & GAMBLE COMPANY (US) | 2000-02-15 | — | — | US | claimed |
| US-5872142-A | 1,3-DIOXANE OR -DIOXOLANE DERIVATIVES OF 1H-1,2,4-TRIAZOLE | THE PROCTER & GAMBLE COMPANY (US) | 1999-02-16 | — | — | US | claimed |
| US-5770616-A | 1,2,4-TRIAZOLE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1998-06-23 | — | — | US | claimed |
| EP-0841920-A2 | USE OF 1H-1,2,4-TRIAZOLE DERIVATIVES FOR INHIBITING THE GROWTH OF CANCERS | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-20 | — | — | EP | claimed |
| EP-0831814-A1 | USE OF 1,2,4-TRIAZOLE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCERS | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-01 | — | — | EP | claimed |
| WO-1997005872-A2 | USE OF 1H-1,2,4-TRIAZOLE DERIVATIVES FOR INHIBITING THE GROWTH OF CANCERS | THE PROCTER & GAMBLE COMPANY (US) | 1997-02-20 | — | — | WO | claimed |
| WO-1996040119-A1 | USE OF 1,2,4-TRIAZOLE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCERS | THE PROCTER & GAMBLE COMPANY (US) | 1996-12-19 | — | — | WO | claimed |
| EP-0252875-B1 | MICROBICIDAL AGENT | CIBA-GEIGY AG (CH) | 1993-01-27 | — | — | EP | claimed |
| EP-0252875-A2 | Microbicidal agent | CIBA-GEIGY AG (CH) | 1988-01-13 | — | — | EP | claimed |
| US-4542146-A | Process for the protection of wood and coatings against deterioration by microorganisms | JANSSEN PHARMACEUTICA N.V. (BE) | 1985-09-17 | — | — | US | claimed |
| EP-0038109-B1 | AGENTS AND METHOD FOR THE PROTECTION OF COATINGS AND WOOD AND OTHER NON-LIVING ORGANIC SUBSTRATES FROM DETERIORATION BY MICRO-ORGANISMS | JANSSEN PHARMACEUTICA N.V. (BE) | 1984-08-29 | — | — | EP | claimed |
| EP-0038109-A2 | Agents and method for the protection of coatings and wood and other non-living organic substrates from deterioration by micro-organisms | JANSSEN PHARMACEUTICA N.V. (BE) | 1981-10-21 | — | — | EP | claimed |
| US-4160838-A | FUNGICIDES, BACTERICIDES | JANSSEN PHARMACEUTICA N.V. (BE) | 1979-07-10 | — | — | US | claimed |
| US-4079062-A | ANTIMICROBIAL, PLANT GROWTH REGULATORS; 1-(B-ARYL)ETHYL-1H-1,2,4-TRIAZOLE KETALS | JANSSEN PHARMACEUTICA N.V. (BE) | 1978-03-14 | — | — | US | claimed |
| US-20170049105-A1 | FUNGICIDAL MIXTURES BASED ON TRIAZOLES | BASF SE (DE) | 2017-02-23 | — | — | US | disclosed |
| US-20110245280-A1 | FRUGICIDAL MIXTURES BASED ON TRIAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 2011-10-06 | — | — | US | disclosed |
| US-6441016-B2 | COMPRISING A COPPER COMPOUND, AN ALKANOLAMINE, AND A PHOSPHONIUM COMPOUND OR A TRIAZOLE COMPOUND AND AN EMULSIFIER; GOOD ACTIVITY AGAINST BASIDIOMYCETES | DR. WOLMAN GMBH (DE) | 2002-08-27 | — | — | US | disclosed |
| US-20010047015-A1 | Pharmaceutical composition for inhibiting the growth of cancers | CAMDEN JAMES BERGER (US) | 2001-11-29 | — | — | US | disclosed |
| US-20010039291-A1 | Compositions and methods of treatment for cancer or viral infections | THE PROCTER & GAMBLE COMPANY | 2001-11-08 | — | — | US | disclosed |
| US-20010006684-A1 | WOOD PRESERVATIVES | GOETTSCHE REIMER (DE) | 2001-07-05 | — | — | US | disclosed |
| US-6228876-B1 | ADMINISTERING 1-(1,3-DIOXOLAN-2-YLMETHY)L- OR 1-(1,3-DIOXAN-2-YLMETHYL)-1H-1,2,4-TRIAZOLE DERIVATIVE | THE PROCTER & GAMBLE COMPANY | 2001-05-08 | — | — | US | disclosed |
| US-6200992-B1 | ADMINISTERING 1H-1,2,4-TRIAZOLE DERIVATIVE, CHEMOTHERAPEUTIC AGENT, AND POTENTIATOR; ANTICARCINOGENIC, ANTITUMOR AGENTS | THE PROCTER & GAMBLE COMPANY | 2001-03-13 | — | — | US | disclosed |
| US-6110953-A | Pharmaceutical composition for inhibiting the growth of cancers | THE PROCTER & GAMBLE COMPANY (US) | 2000-08-29 | — | — | US | disclosed |
| US-6025377-A | 1H-1,2,4-TRIAZOLE DERIVATIVE. THESE COMPOUNDS CAN ALSO BE USED TO TREAT VIRAL INFECTIONS. | THE PROCTER & GAMBLE COMPANY (US) | 2000-02-15 | — | — | US | disclosed |
| EP-0954309-A1 | HIV AND CANCER TREATMENT | THE PROCTER & GAMBLE COMPANY (US) | 1999-11-10 | — | — | EP | disclosed |
| US-5872142-A | 1,3-DIOXANE OR -DIOXOLANE DERIVATIVES OF 1H-1,2,4-TRIAZOLE | THE PROCTER & GAMBLE COMPANY (US) | 1999-02-16 | — | — | US | disclosed |
| US-5853766-A | Wood preservatives | DR. WOLMAN GMBH (DE) | 1998-12-29 | — | — | US | disclosed |
| WO-1998051303-A1 | HIV AND CANCER TREATMENT | THE PROCTER & GAMBLE COMPANY (US) | 1998-11-19 | — | — | WO | disclosed |
| US-5770616-A | 1,2,4-TRIAZOLE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1998-06-23 | — | — | US | disclosed |
| EP-0831814-A1 | USE OF 1,2,4-TRIAZOLE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCERS | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-01 | — | — | EP | disclosed |
| US-5635217-A | IMPREGNATING WITH A COPPER COMPOUND, AN ALKANOLAMINE, AN EMULSIFIER AND/OR A PHOSPHONIUM COMPOUND | DR. WOLMAN GMBH (DE) | 1997-06-03 | — | — | US | disclosed |
| WO-1996040119-A1 | USE OF 1,2,4-TRIAZOLE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCERS | THE PROCTER & GAMBLE COMPANY (US) | 1996-12-19 | — | — | WO | disclosed |
| EP-0482433-B1 | Wood preserving agents containing polymeric nitrogen compounds and metal fixing acids | WOLMAN GMBH DR (DE) | 1995-01-25 | — | — | EP | disclosed |
| EP-0514644-B1 | Wood preservative | WOLMAN GMBH DR (DE) | 1994-11-02 | — | — | EP | disclosed |
| EP-0423674-B1 | Wood preservative containing polymeric nitrogen compounds | WOLMAN GMBH DR (DE) | 1994-09-21 | — | — | EP | disclosed |
| US-5186947-A | Copper and zinc compounds, a metal fixing acid, and a polyethylenimine washout reducing compound | DR. WOLMAN GMBH (DE) | 1993-02-16 | — | — | US | disclosed |
| US-5187194-A | Metal compound of an n-organyldiazeniumdioxy compound and a complexing agent | DR. WOLMAN GMBH (DE) | 1993-02-16 | — | — | US | disclosed |
| EP-0252875-B1 | MICROBICIDAL AGENT | CIBA-GEIGY AG (CH) | 1993-01-27 | — | — | EP | disclosed |
| EP-0514644-A2 | Wood preservative | Dr. Wolman GmbH (DE) | 1992-11-25 | — | — | EP | disclosed |
| EP-0482433-A1 | Wood preserving agents containing polymeric nitrogen compounds and metal fixing acids | Dr. Wolman GmbH (DE) | 1992-04-29 | — | — | EP | disclosed |
| US-5026719-A | Synergistic combination of triazole fungicide and morpholine alkylarylsulfonate | CIBA-GEIGY CORPORATION (US) | 1991-06-25 | — | — | US | disclosed |
| US-4742071-A | Novel 2-aryl-2-azolylmethyl-1,3-dioxepine fungicides | BAYER AKTIENGESELLSCHAFT (DE) | 1988-05-03 | — | — | US | disclosed |
| EP-0252875-A2 | Microbicidal agent | CIBA-GEIGY AG (CH) | 1988-01-13 | — | — | EP | disclosed |
| EP-0102578-B1 | 2-ARYL-2-AZOLYL-METHYL-1,3-DIOXEPINES | BAYER AG (DE) | 1986-07-30 | — | — | EP | disclosed |
| US-4559355-A | AGRICULTURE | BAYER AKTIENGESELLSCHAFT (DE) | 1985-12-17 | — | — | US | disclosed |
| EP-0102578-A2 | 2-Aryl-2-azolyl-methyl-1,3-dioxepines | BAYER AG (DE) | 1984-03-14 | — | — | EP | disclosed |
| EP-0102578-A2 | 2-Aryl-2-azolyl-methyl-1,3-dioxepines | BAYER AG (DE) | 1984-03-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010047015-A1 | Pharmaceutical composition for inhibiting the growth of cancers | MKI67, CCNI, MYC | CYP3A4 152/4885THRB 1259/4885CYP2C9 1609/4885 |
| US-20110245280-A1 | FRUGICIDAL MIXTURES BASED ON TRIAZOLES | CYP4B1, CYP4F2, CYP4F3 | CYP3A4 8/4885THRB 672/4885CYP2C9 15/4885 |
| US-20170049105-A1 | FUNGICIDAL MIXTURES BASED ON TRIAZOLES | CYP3A43, CYP3A7, CYP2E1 | CYP3A4 14/4885THRB 1074/4885CYP2C9 22/4885 |
| US-20010006684-A1 | WOOD PRESERVATIVES | PHOSPHO1, PSEN1, PSEN2 | CYP3A4 533/4885THRB 3440/4885CYP2C9 2328/4885 |
| US-20010039291-A1 | Compositions and methods of treatment for cancer or viral infections | TP53, HAVCR2, MAVS | CYP3A4 1564/4885THRB 1657/4885CYP2C9 4491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.